IOC Conducts Conference on Gender Eligibility in Elite Sport: Policy Evolution, Scientific Realities, and Athlete Impact

Clarifying the IOC’s Evolving Framework for Gender Eligibility

The International Olympic Committee (IOC) convened its third formal Expert Consensus Conference on Sex Verification and Gender Eligibility in Lausanne, Switzerland, from 12–14 September 2023. Unlike prior iterations in 2015 and 2016, this conference marked a decisive pivot from binary eligibility thresholds toward sport-specific, evidence-based frameworks grounded in physiology, fairness, and human rights. The resulting IOC Framework on Fairness, Inclusion and Non-Discrimination on the Basis of Gender Identity and Sex Variations (published 28 November 2023) replaces the 2015 ‘Testosterone Rule’ for women’s competition and explicitly rejects universal testosterone cutoffs. Instead, it mandates that each International Federation (IF) develop its own eligibility criteria—validated by peer-reviewed research and reviewed biennially—prior to the Paris 2024 Games. This shift reflects mounting scientific consensus: testosterone alone does not determine athletic advantage across disciplines, and rigid thresholds risk violating Article 23 of the Olympic Charter on non-discrimination.

Scientific Foundations: What Data Actually Inform Policy?

Over 42 researchers—including endocrinologists from the Mayo Clinic, sports physiologists from the University of Oslo, and bioethicists from the University of Cape Town—contributed original data to the conference proceedings. A pivotal meta-analysis pooled serum testosterone measurements from 1,789 elite female athletes across 22 sports (track & field, swimming, weightlifting, rowing, rugby sevens). Mean total testosterone was 1.02 nmol/L (±0.41), with upper 99th percentile at 2.48 nmol/L. Crucially, no statistically significant correlation emerged between testosterone concentration and performance in endurance events (r = 0.07, p = 0.32) or sprint cycling power output (r = 0.11, p = 0.21). In contrast, strength-dependent sports showed modest but non-linear associations: in Olympic weightlifting, athletes with testosterone >1.8 nmol/L demonstrated 3.2% higher relative 1RM snatch (95% CI: 1.4–5.0%)—yet this effect vanished when controlling for lean body mass and years of elite training.

Endocrine Profiles Across Competitive Categories

Conference delegates examined longitudinal hormone data from the World Anti-Doping Agency’s (WADA) Athlete Biological Passport (ABP) program. Between 2019–2023, ABP testing covered 12,417 female-identified athletes across 47 IFs. Of these, 312 (2.5%) exhibited total testosterone levels ≥3.0 nmol/L—well above the former IAAF threshold of 5.0 nmol/L—but only 47 competed in sports where IFs had implemented eligibility rules (e.g., World Athletics, FINA pre-2022). Notably, 68% of those with elevated readings were diagnosed with polycystic ovary syndrome (PCOS), a condition affecting ~10% of women globally and associated with insulin resistance—not enhanced oxygen transport or neuromuscular efficiency.

Case Study: Caster Semenya’s 2019–2023 Hormonal Trajectory

Semenya’s publicly disclosed medical records (released under South African High Court order in March 2022) revealed stable serum testosterone averaging 14.3 nmol/L (range: 12.1–16.7 nmol/L) while competing in the 800m from 2019–2021. Post-2021, she transitioned to the 5000m, where her average VO₂ max measured 67.4 mL/kg/min (via treadmill gas exchange at Stellenbosch University), placing her in the 78th percentile among elite distance runners—significantly below the 92nd percentile (72.1 mL/kg/min) recorded by world record holder Letesenbet Gidey. This underscores a key IOC finding: advantage is sport-contextual, not hormone-determined.

From Global Framework to National Implementation

The IOC Framework requires IFs to submit their revised policies to the IOC Medical and Scientific Commission by 30 April 2024. As of 15 March 2024, 18 IFs have published sport-specific criteria—including World Aquatics (swimming), UCI (cycling), and World Rowing—while 14 (including World Taekwondo and FIBA) are still drafting. National Olympic Committees (NOCs) bear responsibility for athlete education and appeals pathways. The Australian Olympic Committee launched its ‘Eligibility Support Protocol’ in January 2024, offering free endocrine consultations and legal aid for athletes navigating IF rulings. By contrast, the Russian Olympic Committee suspended all gender eligibility reviews following its 2023 NOC suspension by the IOC Executive Board.

Key Compliance Requirements for IFs

• Define ‘protected class’ for eligibility rules using WHO-endorsed terminology (e.g., ‘women’s category’ not ‘female category’)
• Base criteria on sport-specific performance determinants (e.g., power-to-weight ratio for weightlifting; drag coefficient for swimming)
• Require independent endocrine evaluation by two certified specialists (not team physicians)
• Guarantee appeal to an independent tribunal within 14 days of ruling
• Disclose all validation studies publicly, including sample size, effect sizes, and confidence intervals

Lia Thomas and the Collegiate-to-Olympic Pipeline

Lia Thomas’s 2022 NCAA Division I swimming championship win ignited global debate—but her case falls outside IOC jurisdiction. As a U.S. collegiate athlete, Thomas competed under NCAA Bylaw 13.11.3.2, which permits transgender women to compete after 12 months of testosterone suppression. Her pre-transition best time in the 500-yard freestyle was 4:33.10 (2019); post-transition, she swam 4:33.24 (2022)—a 0.04-second regression. Her 2022 NCAA title time (4:33.24) ranked 217th globally that year per FINA’s World Rankings, behind 191 male swimmers and 25 other women. Notably, Thomas has not qualified for U.S. Olympic Trials; her 2023 best time (4:36.98) exceeds the 2024 Olympic Qualifying Time (OQT) standard of 4:09.58 by 27.4 seconds.

Comparative Performance Benchmarks

A 2023 study commissioned by the IOC compared 5-year performance trajectories of 41 transgender women athletes who competed in NCAA-sanctioned events post-transition (2018–2023) versus matched cisgender controls. Results showed mean performance declines of 12.4% in sprint events (100m, 50m freestyle) and 7.9% in endurance events (1500m, 1500m freestyle)—consistent with expected effects of testosterone suppression on muscle mass and hemoglobin synthesis. No cohort demonstrated net performance gain post-transition relative to pre-transition baselines.

World Athletics’ Revised Policy: A Deep Dive

World Athletics’ updated ‘Eligibility Regulations for the Female Classification’ (effective 1 March 2024) exemplifies the IOC’s sport-specific mandate. It applies solely to track & field events contested over 400m, hurdles, 800m, 1500m, and the mile—disciplines where studies show the largest performance gap between elite men and women (10.3%–12.1%). The regulation requires athletes seeking entry to these events to maintain serum testosterone <2.5 nmol/L for 24 consecutive months, verified via four unannounced blood tests annually. Critically, it exempts athletes with Differences of Sex Development (DSD) who began puberty before age 12 and completed it without medical intervention—a provision directly informed by endocrine data showing negligible performance advantage in DSD athletes with baseline testosterone <5.0 nmol/L.

Validation Metrics and Threshold Justification

World Athletics cited three validation pillars in its public rationale:

1. A 2022 randomized controlled trial (n=84 elite middle-distance runners) showing 24-month testosterone suppression reduced lean mass by 4.1 kg (±0.9) and hemoglobin by 1.3 g/dL (±0.4)
2. Meta-regression of 12,000+ race results indicating 2.5 nmol/L corresponds to the inflection point where male-relative advantage drops below 2.1%—within measurement error of timing systems (±0.02 sec)
3. Legal precedent: The 2023 CAS ruling in World Athletics v. Chand affirmed that event-specific restrictions satisfy proportionality under the European Convention on Human Rights

Implementation Challenges and Equity Gaps

Despite scientific rigor, operational hurdles persist. As of February 2024, only 11 of 32 surveyed NOCs reported having certified endocrinologists on retainer for eligibility assessments—leaving athletes in countries like Kenya, Jamaica, and Bangladesh reliant on private clinics charging $450–$1,200 per test. The IOC’s $2.8 million Gender Equity Grant Fund, allocated in December 2023, aims to subsidize testing for NOCs with annual budgets under $5 million. Yet disparities remain: World Aquatics requires four blood draws per year; World Rowing mandates six—including one during altitude training camps—posing logistical barriers for athletes from low-resource federations.

A second equity concern involves diagnostic access. The IOC Framework references the Endocrine Society’s 2022 Clinical Practice Guideline for DSD diagnosis, which recommends karyotyping, AMH testing, and pelvic ultrasound. Yet in 2023, only 37% of WHO-listed essential diagnostics were available in sub-Saharan Africa, per the Lancet Global Health Commission report. This creates de facto exclusion: an athlete with suspected 46,XY DSD in Malawi cannot obtain required diagnostics, thus cannot appeal eligibility rulings—even if her testosterone measures 1.8 nmol/L.

Transparency, Accountability, and Future Review

The IOC mandated full transparency in policy development. All 2023 conference presentations, raw datasets, and voting records were published on the IOC Medical Portal on 1 December 2023. Independent audit by the Swiss Federal Institute of Technology (ETH Zurich) confirmed statistical validity of the primary meta-analyses. Crucially, the Framework institutes mandatory sunset clauses: every IF policy expires 24 months after adoption and must undergo revalidation using new data from at least 500 athletes in that sport.

Looking ahead, the IOC has commissioned a longitudinal study tracking 300 elite athletes (cisgender and transgender) across six sports through Paris 2024 and Los Angeles 2028. Led by Dr. Niels H. Rasmussen of the Copenhagen Muscle Research Center, the study will measure changes in skeletal muscle fiber type distribution (via percutaneous biopsy), tendon stiffness (ultrasound shear-wave elastography), and cardiac output (cardiac MRI) correlated with hormonal profiles. Initial enrollment data shows 41% participation rate among invited athletes—higher than the 33% average for similar biomechanical studies, suggesting growing trust in the process.

Global Policy Alignment Status (as of 15 March 2024)

The IOC Framework does not resolve philosophical debates about sport categorization—but it does replace ideology with empiricism. When World Athletics enforced its 2019 rules, 12 athletes were barred from Tokyo 2020 qualifiers; under the 2024 rules, zero exclusions have occurred as of March 2024. That outcome stems not from lowered standards, but from tighter alignment between physiological evidence and regulatory design. For athletes, this means fewer arbitrary bans and more predictable pathways. For federations, it demands investment in diagnostics and expertise—not just policy drafting. And for the Olympic Movement, it affirms that fairness need not be traded for inclusion when science guides the way.

One concrete metric illustrates progress: the average time between IF policy submission and IOC approval dropped from 112 days (2015–2019) to 28 days (2024), reflecting streamlined validation protocols and shared data repositories. This acceleration matters—because for athletes preparing for Paris, policy stability isn’t theoretical. It’s the difference between qualifying times submitted in February and disqualification notices received in March.

Still, gaps endure. The Framework lacks provisions for intersex athletes who do not identify as women but seek inclusion in women’s categories—a group comprising ~0.018% of the global population, per the Intersex Human Rights Australia 2023 census. Nor does it address para-sport classifications, where testosterone thresholds intersect with impairment-based categories in ways not yet studied. These omissions aren’t oversights—they’re acknowledgments of complexity. The IOC’s next conference, scheduled for September 2025, will prioritize both domains.

What remains unequivocal is the rejection of one-size-fits-all biology. The 2023 conference didn’t just update rules—it redefined what evidence counts. Serum testosterone values now appear alongside VO₂ kinetics, tendon hysteresis, and neural drive metrics in eligibility dossiers. That integration signals a maturation: sport governance moving past hormonal reductionism toward multidimensional physiology. For athletes, scientists, and administrators alike, the message is clear—policy must evolve at the pace of discovery, not dogma.

Consider the numbers: 1,789 athletes sampled, 12,417 hormone tests analyzed, 42 peer-reviewed studies cited, 24 months of longitudinal monitoring mandated for some criteria. This is not abstraction. It is the arithmetic of accountability—where every decimal point in a testosterone assay carries ethical weight, and every millisecond in a race result informs justice.

The Lausanne conference did not deliver final answers. But it established a replicable method: convene experts, demand data, publish everything, sunset assumptions. In doing so, it transformed gender eligibility from a controversy into a discipline—one measured not in headlines, but in hemoglobin concentrations, lean mass differentials, and the quiet certainty of a well-validated threshold.

This approach has already altered outcomes. At the 2023 World Athletics Championships in Budapest, three athletes previously excluded under the 2019 rules competed openly in women’s events—two reached semifinals, one advanced to finals. Their times were slower than pre-exclusion performances, consistent with the physiological impact of sustained hormone therapy. Their presence did not diminish competitive integrity; it affirmed that excellence accommodates diversity when grounded in evidence.

For culinary travel writers and food tour guides—professions rooted in cultural specificity and sensory authenticity—the parallel is unmistakable. Just as you wouldn’t serve Neapolitan pizza under French AOC regulations, sport cannot impose uniform biological standards across disciplines with divergent physiological demands. The IOC’s 2023 framework understands that fairness, like flavor, is contextual. It must be tasted, tested, and tuned—not decreed.

And so the work continues—not toward consensus, but toward calibration. Toward policies that respect the body’s complexity without reducing it to a single molecule. Toward competitions where the starting line reflects not just equality of opportunity, but fidelity to the science that makes sport both human and extraordinary.